Related Experiment Video
Updated: Jun 2, 2026

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Uric Acid-to-Albumin Ratio Is Associated with Left Ventricular Diastolic Function in Patients with No Significant
Takafumi Kawaguchi1, Yukihiro Fukuda1, Naoya Hironobe1
1Department of Cardiovascular Medicine, Hiroshima Prefectural Hospital.
Insights
The uric acid-to-albumin ratio (UAR) is linked to impaired left ventricular (LV) diastolic function in patients without significant heart perfusion issues. This finding suggests UAR may indicate early diastolic dysfunction detectable by gated SPECT imaging.
Area of Science:
- Cardiology
- Biomarkers
- Medical Imaging
Background:
- The uric acid-to-albumin ratio (UAR) is recognized as a marker for inflammation and cardiovascular disease prognosis.
- The association between UAR and left ventricular (LV) diastolic function has not been previously established.
Purpose of the Study:
- To investigate the relationship between the UAR and LV diastolic parameters.
- To assess if UAR is associated with diastolic function in patients without significant perfusion abnormalities using gated myocardial perfusion single-photon emission computed tomography (SPECT).
Main Methods:
- Retrospective analysis of 216 patients with preserved ejection fraction and no significant perfusion abnormalities.
- LV diastolic parameters, including peak filling rate (PFR) and one-third mean filling rate (1/3 MFR), were measured using gated SPECT.
- Serum uric acid and albumin levels were analyzed to calculate the UAR.
Main Results:
- Significant inverse associations were found between UAR and both PFR (r = -0.22, P = 0.001) and 1/3 MFR (r = -0.23, P = 0.001).
- Multivariate analysis confirmed UAR as a significant independent factor associated with PFR (β = -0.16, P = 0.024) and 1/3 MFR (β = -0.14, P = 0.047).
- Age and LV dimensions/mass were also independently associated with diastolic parameters.
Conclusions:
- The UAR is significantly associated with impaired LV diastolic function in patients without significant perfusion abnormalities.
- Gated SPECT-derived diastolic parameters are influenced by the UAR, suggesting its potential role in identifying early diastolic dysfunction.
Abstract:
The ratio of uric acid to albumin is a marker of not only inflammation, but also prognosis of cardiovascular disease. However, whether this ratio is associated with left ventricular (LV) diastolic function remains unknown. This study tested the hypothesis that the uric acid-to-albumin ratio (UAR) is associated with LV diastolic parameters derived from gated myocardial perfusion single-photon emission computed tomography (SPECT) in patients with no significant perfusion abnormalities.Participants in this retrospective study comprised 216 patients with no significant perfusion abnormalities and preserved ejection fraction. The peak filling rate (PFR) and one-third mean filling rate (1/3 MFR) were obtained as LV diastolic parameters using gated SPECT. Serum levels of uric acid and albumin were also examined.Significant associations were observed between the UAR and both the PFR (r = -0.22, P = 0.001) and 1/3 MFR (r = -0.23, P = 0.001). Multivariate linear regression analysis was performed to determine factors associated with LV diastolic parameters. Age (β = -0.14, P = 0.045), LV end-diastolic volume (β = -0.26, P = 0.001), and the UAR (β = -0.16, P = 0.024) were significantly associated with the PFR. Moreover, age (β = -0.19, P = 0.004), LV mass index (β = -0.21, P = 0.001), and the UAR (β = -0.14, P = 0.047) were significantly associated with the 1/3 MFR.These results demonstrate that the UAR is associated with LV diastolic function, as derived from gated SPECT in patients with no significant perfusion abnormalities.
Related Concept Videos
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
